Katie Hasson

Katie Hasson, PhD, writes, speaks, researches, and teaches about the social and political aspects of human genetic and reproductive technologies. Katie earned her PhD in Sociology with a Designated Emphasis in Women, Gender, and Sexuality from the University of California, Berkeley, and was previously Assistant Professor of Sociology and Gender Studies at the University of Southern California.

Profile picture for user Katie Hasson

Publications

photo of a world cloud
By Katie Hasson and Marcy Darnovsky, Development Journal | 01.14.2020

As genetic technologies merge with forensics, medicine, and human reproduction, renewed eugenic temptations are arising. The prospect of heritable genetic...

An embryo being fertilized
By Katie Hasson, The Hill | 06.10.2019

Late last year, scientist He Jiankui announced the birth of the world’s first genetically modified babies. He deployed a...

Gloved hands moving small test tubes from one test tube rack to another
By Katie Hasson and Marcy Darnovsky, The Guardian | 11.27.2018

The fierce global controversy over whether to alter the genes of future children and generations just got fiercer. On the...

In the News

DNA graphic
By Lisa Eadicicco, CNN [cites CGS' Katie Hasson] | 03.30.2025

23andMe, a standard-bearer for the at-home health movement, announced on March 23 that it has filed for Chapter 11 bankruptcy...

many overlapping strands of DNA
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025

Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA...

superbaby graphic
By Staff [cites CGS' Katie Hasson], The New York Times Upfront | 02.17.2025

A young couple wants to have a baby, but they’re worried it’ll carry a disease that runs in the family...

Biopolitical Times

This week in London, some 400 people from around the world – including scientists, bioethicists, patients, journalists, civil society groups...

 Rehua, CC BY-SA 3.0, via Wikimedia Commons

James Wilson, director of the Gene Therapy Program at Penn’s...